Marken expands clinical trial kit building service into Singapore

Published: 9-Aug-2013
Packaging

Logistics firm is evaluating an additional facility in Florida, US or Brazil in the future


Marken, a US headquartered supply chain solutions provider to the pharmaceutical and life sciences industry, has expanded its clinical trial kit-building operations into Singapore due to growing demand.

The unit is managed by dedicated staff and supported by the GMP operators and QA personnel who operate the depot facility. The depot/kit facility is also adjacent to Marken's Singapore distribution hub, which is located near Chiangi airport. Marken staff can therefore receive drug product and kit materials at the depot, assemble and store kits, store drug product and distribute all clinical materials to investigator sites throughout Asia.

The addition of the Singapore site is part of Marken’s ongoing global expansion plan. With kit-building locations operational in Hamburg and now Singapore, Marken is evaluating an additional facility in either Miami, Florida or Brazil in the coming months.

Marken currently produces 15,000 kits each month and distributes more than 350,000 kits annually to investigator sites around the world.

Wes Wheeler, Marken’s Chief Executive, said, ‘Our ability to assemble kits in Singapore gives us a solid platform in Asia and again enhances our portfolio of services to clients in the region.’

  • Companies:
  • Marken
See more

You may also like

Packaging

Innovating primary packaging for parenteral drugs: challenges and future directions

Read more
The new challenges brought about by the pandemic call for an increasingly scientific approach to the evolution of single packaging elements in order to anticipate the needs of new drug formulations and guarantee a more enhanced, measurable and stable level of performance

Trending Articles

  1. AstraZeneca to stop production of Pulmicort pMDI Agreements with SkyePharma expected to be terminated
  2. Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the market and capitalise on new opportunities
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Prefilled syringes: glass or polymer? Prefilled syringes come in many varieties with the most fundamental difference being the material they are made of – glass or polymer. Manufacturer Schott considers how to make the right choice
  4. Understanding the real risks of packaging When it comes to GMP production, specifying the type of packaging to be taken into the cleanroom is an important consideration. Dr Christoph Strubl, Managing Director of packaging company STRUBL, discusses the need for specialised cleanroom packaging
  5. Schott Pharma AG and Co. KGaA Advanced Drug Containment and Delivery Solutions from SCHOTT Pharma

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Packaging

Innovating primary packaging for parenteral drugs: challenges and future directions

The new challenges brought about by the pandemic call for an increasingly scientific approach to the evolution of single packaging elements in order to anticipate the needs of new drug formulations and guarantee a more enhanced, measurable and stable level of performance
Manufacturing

Leybold launches Duradry vacuum pump for harsh processes

Advanced technology designed for reliability and efficiency
Packaging

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
Packaging

Dual-chamber packaging systems as a simplification factor in the supply chain

Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
Packaging

Bormioli Pharma to digitise package leaflets using augmented reality

The project is part of the Bormioli Pharma Invents innovation programme, which aims to provide concrete answers to some of the most important challenges in the pharmaceutical packaging sector.
Packaging

How augmented reality could impact healthcare and pharma packaging manufacturing

Research and Markets predicts a consistent growth for the AR market in healthcare over the next few years. The expected value of the AR market is projected to reach 152 billion dollars by 2030
Packaging

Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future

To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack
Subscribe now